DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hyperstat (Diazoxide) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

HYPERSTAT SUMMARY

HYPERSTAT® I.V.
brand of diazoxide, USP
Injection

HYPERSTAT I. V. Injection is a non-diuretic benzothiadiazine antihypertensive agent. Each ampule (20 mL) contains 300 mg diazoxide, USP, in a clear, sterile, colorless aqueous solution; the pH is adjusted to approximately 11.6 with sodium hydroxide.

HYPERSTAT I.V. Injection is indicated for short-term use in the emergency reduction of blood pressure in severe, nonmalignant and malignant hypertension in hospitalized adults; and in acute severe hypertension in hospitalized children, when prompt and urgent decrease of diastolic pressure is required. Treatment with orally effective antihypertensive agents should not be instituted until blood pressure has stabilized. The use of HYPERSTAT I.V. Injection for longer than 10 days is not recommended.

HYPERSTAT I.V. Injection is ineffective against hypertension due to pheochromocytoma.


See all Hyperstat indications & dosage >>

HYPERSTAT NEWS HIGHLIGHTS

Published Studies Related to Hyperstat (Diazoxide)

No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet. [2007.07]

Diazoxide-mediated insulin suppression in obese men: a dose-response study. [2005.05]

Neuroprotective effect of diazoxide on brain injury induced by cerebral ischemia/reperfusion during deep hypothermia. [2008.05.15]

Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers. [2008.05]

Involvement of amlodipine, diazoxide, and glibenclamide in development of morphine tolerance in mice. [2008.04]

more >>

Clinical Trials Related to Hyperstat (Diazoxide)

Open-Label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations [Active, not recruiting]

Diazoxide Choline in Hypertriglyceridemia [Recruiting]

Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men [Completed]

Efficacy of Diazoxide in Type 1 Diabetes [Active, not recruiting]

DZX Mediated Insulin Suppression in Obese Men [Not yet recruiting]

more >>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008